Burning Rock Biotech Ltd (BNR) stock
BNRNasdaqServices-Medical Laboratories
$12.50−0.24 (-1.88%)
Close on Nov 17, 2026Market cap $136.07MP/E –Yield –
Burning Rock Biotech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Burning Rock Biotech's price to sales ratio was 12.7× on Jan 29, 2021.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jan 29, 2021 | 12.7× | +2.8 |
| 2020 | Dec 31, 2020 | 9.9× | – |
See a number that looks wrong?